Moving your cell therapy clinical trial beyond Phase I is an exciting time, marking a significant milestone. There are many therapeutic developers working to address critical patient needs in oncology, auto-immune, regenerative medicine, and other spaces.
NVIDIA doubles down on AI in healthcare with drug discovery deals – Pharmaceutical Technology
Share this article Concurrent with the partnerships, NVIDIA also released a new suite of healthcare microservices that includes a collection of models for drug discovery